STOCK TITAN

[144] RECURSION PHARMACEUTICALS, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Recursion Pharmaceuticals, Inc. (RXRX) filed a notice covering a proposed sale of 100,000 Class A shares through Fidelity Brokerage Services LLC on or after July 13, 2026. These are noted as founders shares originally acquired on April 20, 2021 as compensation.

The filing also lists multiple recent Class A share sales over the past three months by Christopher C. Gibson, the Gibson Family Trust, and Lahwran-3 LLC, with individual transactions ranging from 40,000 to 340,440 shares and corresponding dollar amounts disclosed for each sale.

Positive

  • None.

Negative

  • None.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature